| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/29/2023 | 780.9% | Benchmark | → $2.5 | Reiterates | Buy → Buy |
| 05/17/2023 | 780.9% | Benchmark | $3 → $2.5 | Maintains | Buy |
| 03/09/2023 | 957.08% | Benchmark | → $3 | Reiterates | → Buy |
| 12/23/2022 | 957.08% | Benchmark | → $3 | Initiates Coverage On | → Buy |
What is the target price for Nutex Health (NUTX)?
The latest price target for Nutex Health (NASDAQ: NUTX) was reported by Benchmark on August 29, 2023. The analyst firm set a price target for $2.50 expecting NUTX to rise to within 12 months (a possible 780.90% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nutex Health (NUTX)?
The latest analyst rating for Nutex Health (NASDAQ: NUTX) was provided by Benchmark, and Nutex Health reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Nutex Health (NUTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nutex Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nutex Health was filed on August 29, 2023 so you should expect the next rating to be made available sometime around August 29, 2024.
Is the Analyst Rating Nutex Health (NUTX) correct?
While ratings are subjective and will change, the latest Nutex Health (NUTX) rating was a reiterated with a price target of $0.00 to $2.50. The current price Nutex Health (NUTX) is trading at is $0.28, which is within the analyst's predicted range.